OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Close contact;Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 127
Country: China
Location: Guangzhou, Hong Kong
Study period:  Sep 09 2004 to  Nov 11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 127
Country: China
Location: Guangzhou, Hong Kong
Study period:  Sep 09 2004 to  Nov 11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 17
Maximum age: 74
Sample size: 477
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 17 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 17
Maximum age: 74
Sample size: 477
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 17 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 17
Maximum age: 74
Sample size: 477
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 17 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 17
Maximum age: 74
Sample size: 477
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 17 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 30.8
Unit: Percentage (%)
CFR/IFR numerator: 24
CFR/IFR denominator: 78
CFR/IFR method: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 13
Maximum age: 84
Sample size: 78
Country: Taiwan,  China
Location: Chang Gung Memorial Hospital in Linkou and Kaoshiung
Memorial Hospital in Linkou and Kaoshiung
Study period:  Aug 08 2003 to  Feb 02 2004
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 18.7
Unit: Days
Value type: Mean
Uncertainty single value: 12 (Standard Deviation)
Combined uncertainty: 12 (Standard Deviation)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 13
Maximum age: 84
Sample size: 78
Country: Taiwan,  China
Location: Chang Gung Memorial Hospital in Linkou and Kaoshiung
Study period:  Aug 08 2003 to  Feb 02 2004
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Occupation;Other
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 13
Maximum age: 84
Sample size: 78
Country: Taiwan,  China
Location: Chang Gung Memorial Hospital in Linkou and Kaoshiung
Study period:  Aug 08 2003 to  Feb 02 2004
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.16
Unit: Percentage (%)
Value type: Other
Uncertainty single value: 1.35 (Standard Error)
Combined uncertainty: 1.35 (Standard Error)
CFR/IFR method: Adjusted
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:    to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.3
Unit: Percentage (%)
CFR/IFR method: Adjusted
Distribution type: Normal
Distribution parameter 1: 17.3 (Mean)
Distribution parameter 2: 0.92 (Standard deviation)
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:    to 11 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.16
Unit: Percentage (%)
CFR/IFR method: Adjusted
Distribution type: Normal
Distribution parameter 1: 17.16 (Mean)
Distribution parameter 2: 1.35 (Standard deviation)
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:    to 25 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Value type: Standard Deviation
Lower bound: 0.24
Upper bound: 3.69
Bounds: 0.24 - 3.69
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Disaggregated by: Other, Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 9.56
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 6.55
Upper bound: 17.13
Bounds: 6.55 - 17.13
CFR/IFR numerator: 774
CFR/IFR denominator: 8096
CFR/IFR method: Naive
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada, China, Hong Kong SAR,  China, Singapore, Taiwan,  China, Vietnam
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Age
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 345
Country: Taiwan,  China
Study period:    to 12 Oct 10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 345
Country: Taiwan,  China
Study period:    to 12 Oct 10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Admission-Death Delay
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 345
Country: Taiwan,  China
Study period:    to 12 Oct 10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Admission-Discharge Delay
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 345
Country: Taiwan,  China
Study period:    to 12 Oct 10 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 3.567
Unit: No units
Value type: Unspecified
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period: 17 Mar 03 2003 to 1 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 1.7068
Unit: No units
Value type: Unspecified
Epidemic phase: Mid outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period: 1 Apr 04 2003 to 14 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 3.5256
Unit: No units
Value type: Unspecified
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Canada
Study period: 25 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 1.3901
Unit: No units
Value type: Unspecified
Epidemic phase: Mid outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Canada
Study period:    to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 4.4544
Unit: No units
Value type: Unspecified
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period: 8 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 1.2849
Unit: No units
Value type: Unspecified
Epidemic phase: Mid outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period:    to 1 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Epidemic phase: Unspecified
Reproduction number method: Branching process
Disaggregated by: Region, Time
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Guangdong, Shanxi, Beijing, Inner
Mongolia, Tianjin
Study period: 16 Nov 11 2002 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Epidemic phase: Unspecified
Reproduction number method: Branching process
Disaggregated by: Other, Time
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing, Tianjin
Study period: 3 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Lower bound: 10
Upper bound: 20
Bounds: 10 - 20
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing, Tianjin
Study period: 3 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Occupation;Sex
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing, Tianjin
Study period: 3 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Occupation
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing, Tianjin
Study period: 3 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing, Tianjin
Study period: 3 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 11
Unit: Days
Value type: Median
Epidemic phase: Post outbreak
Disaggregated by: Sex
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Sample size: 53
Country: China
Location: Beijing
Study period: 15 Mar 03 2003 to 14 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 5.31
Unit: Percentage (%)
Uncertainty type: Range [Sample]
Uncertainty lower value: 4.86
Uncertainty upper value: 5.87
Combined uncertainty: 4.86 - 5.87 (Range [Sample])
CFR/IFR numerator: 134
CFR/IFR denominator: 2521
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Disaggregated by: Sex
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Sample size: 2521
Country: China
Location: Beijing
Study period: 15 Mar 03 2003 to 14 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Sample size: 1632
Country: China
Location: Beijing
Study period: 15 Mar 03 2003 to 14 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Sample size: 1632
Country: China
Location: Beijing
Study period: 15 Mar 03 2003 to 14 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 5
Unit: Days
Value type: Median
Uncertainty type: Range [Sample]
Uncertainty lower value: 0
Uncertainty upper value: 17
Combined uncertainty: 0 - 17 (Range [Sample])
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 219
Country: China
Location: Beijing
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 225
Country: China
Location: Beijing
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Severe disease
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 225
Country: China
Location: Beijing
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Occupation;Other
Risk factor outcome: Incidence Rate
Risk factor occupation: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 295
Country: Hong Kong SAR,  China
Study period: 12 Apr 04 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Occupation;Other
Risk factor outcome: Incidence Rate
Risk factor occupation: Other
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 295
Country: Hong Kong SAR,  China
Study period: 12 Apr 04 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.09
Unit: No units
Value type: Unspecified
Epidemic phase: Post outbreak
Reproduction number method: Next generation matrix
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period: 25 Mar 03 2003 to 27 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: beta - per capita contact rate per unit of time
Unit: Per day
Lower bound: 0
Upper bound: 1.49
Bounds: 0 - 1.49
Reproduction number method: Compartmental model
Disaggregated by: Time
Country: Hong Kong SAR,  China
Study period: 14 Feb 02 2003 to 3 Jun 06 2003